V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20105865 | 20157691 | 1.51 | 76.5 | Palliative (P) | 2018-08-09 | 2018-08-17 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | ECF | 100094039 |
| 20106119 | 20157692 | null | null | Palliative (P) | 2017-02-23 | 2017-09-27 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | null | COSMIC TRIAL | 101121579 |
| 20106237 | 20157694 | 1.6 | 85 | Palliative (P) | 2017-10-29 | 2017-11-05 | GEMCARBO | N | null | TRABECTEDIN | 100563912 |
| 20106347 | 20157695 | 1.56 | 95.5 | null | 2016-10-04 | 2016-10-07 | CHOP R - 21 days | 02 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 101267204 |
| 20106400 | 20157696 | 1.6 | 104.3 | Palliative (P) | 2018-08-13 | 2018-08-15 | COSMIC TRIAL | 02 | N | RAMUCIRUMAB | 100735055 |
| 20106458 | 20157697 | 1.57 | 87 | Palliative (P) | 2019-06-15 | 2019-10-09 | POLEM TRIAL | 02 | Y | RITUXIMAB | 101531659 |
| 20106829 | 20157698 | 1.66 | 65.4 | null | 2018-03-01 | 2018-03-27 | Bortezomib +/- Dexamethasone | 02 | null | HEPATOBLASTOMA VHR BLOCK A CISPLATIN/DOX | 100609154 |
| 20106930 | 20157699 | 1.49 | 71.9 | Palliative (P) | 2020-12-25 | 2021-01-01 | Bevacizumab + Capecitabine | 02 | null | ERIBULIN | 101426233 |
| 20107700 | 20157700 | 1.65 | 74 | null | 2018-08-18 | 2018-08-18 | CAP + RT | 02 | null | BORTEZOMIB + THALIDOMIDE | 101566200 |
| 20108059 | 20157702 | null | null | null | 2017-05-13 | 2017-05-18 | CISPLATIN + RALTITREXED + Trastuzumab | 02 | N | CISPLATIN + TRASTUZUMAB | 101609991 |
| 20108076 | 20157703 | 1.61 | 68.8 | null | 2018-10-29 | 2018-11-25 | BENDAMUSTINE + CYTARABINE + RITUXIMAB | 02 | null | TOPOTECAN | 100182478 |
| 20108324 | 20157704 | 1.82 | 50.4 | Palliative (P) | 2016-11-03 | 2016-11-17 | CEMIPLIMAB | N | N | CYCLOPHOSPHAMIDE | 100691809 |
| 20108736 | 20157705 | 1.77 | 74.8 | 03 | null | 2017-10-02 | POMALIDOMIDE | null | null | PHITT | 100468534 |
| 20108821 | 20157706 | 1.55 | 80 | 03 | 2017-12-10 | 2017-12-17 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | HYDROXYCARBAMIDE | 101861857 |
| 20108902 | 20157707 | 1.46 | 67.5 | null | 2019-02-26 | 2019-02-26 | ECF | 02 | N | FOXTROT TRIAL | 100854301 |
| 20109923 | 20157708 | 1.65 | 8.9 | Palliative (P) | 2013-05-22 | 2017-03-11 | TEYSUNO | 2 | null | BACILLUS CALMETTE-GUERIN | 101417972 |
| 20110317 | 20157709 | 1.81 | 73 | Curative (C) | 2020-11-12 | 2020-11-22 | Niraparib | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101063964 |
| 20110422 | 20157710 | 1.81 | 0 | null | 2022-03-12 | 2022-03-16 | Eribulin | 02 | N | RITUXIMAB | 101057072 |
| 20111083 | 20157711 | 1.79 | 10.4 | Palliative (P) | 2017-09-15 | 2017-10-10 | EC | 02 | N | MITOMYCIN | 101287389 |
| 20111191 | 20157713 | 1.8 | 76.8 | Palliative (P) | 2020-04-09 | 2020-04-19 | Atezolizumab | 02 | N | VINORELBINE | 100997276 |
| 20111387 | 20157714 | 1.53 | 45.4 | Palliative (P) | 2021-02-03 | 2021-04-10 | NEO-AEGIS TRIAL | null | null | DOXORUBICIN | 101824299 |
| 20112076 | 20157716 | 1.81 | 66 | 03 | null | 2022-03-25 | Bortezomib + Daratumumab | N | N | IRINOTECAN + TEMOZOLOMIDE | 101860498 |
| 20112298 | 20157718 | 1.56 | 57 | null | null | 2016-06-29 | SCOPE 2 TRIAL | 02 | null | CAP + RT | 101600163 |
| 20112329 | 20157719 | 1.56 | 82.4 | Disease modification (D) | 2020-12-24 | 2021-01-13 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101540728 |
| 20112682 | 20157721 | 1.69 | 69 | Adjuvant (A) | 2010-04-05 | 2020-04-26 | DARATUMUMAB | 99 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100909926 |
| 20112751 | 20157722 | null | null | Palliative (P) | 2020-01-20 | 2020-01-22 | Irinotecan + Raltitrexed | 01 | N | CAP + RT | 101260811 |
| 20112881 | 20157723 | 1.7 | 63.7 | Palliative (P) | 2021-06-24 | 2022-01-08 | Rituximab | 01 | null | OLAPARIB | 101400442 |
| 20112947 | 20157724 | 1.69 | null | Curative (C) | 2020-01-25 | 2020-01-27 | PHITT D Carboplatin / doxorubicin . | 02 | null | CARBO + FLUOROURACIL | 101334648 |
| 20113008 | 20157725 | 1.76 | 91.8 | Palliative (P) | 2021-05-29 | 2021-06-21 | Cyclophos + Dex + Lenalidomide | 02 | null | TOPOTECAN | 100159269 |
| 20113281 | 20157728 | 1.69 | 65 | Neo-adjuvant (N) | 2020-05-18 | 2020-05-24 | Fulvestrant + Palbociclib | 02 | null | RAMUCIRUMAB | 101332264 |
| 20113533 | 20157729 | 1.82 | 66.4 | Curative (C) | 2019-12-09 | 2019-12-30 | CAPE + OXALIPLATIN + TRASTUZUMAB | N | Y | CYCLOPHOSPHAMIDE + VINORELBINE | 100225808 |
| 20114769 | 20157732 | 1.65 | 95 | null | 2019-11-09 | 2019-11-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | STREPTOZOCIN + MDG | 101262332 |
| 20115341 | 20157735 | 1.53 | 106.5 | null | 2019-10-24 | 2020-01-22 | INTERAACT trial | 02 | null | CABAZITAXEL | 101484039 |
| 20115640 | 20157737 | 1.49 | 92.1 | null | 2021-03-16 | 2021-03-26 | MITOMYCIN | 02 | null | BACILLUS CALMETTE-GUERIN | 100971912 |
| 20115685 | 20157738 | 1.58 | 105.6 | null | null | 2019-04-11 | FLUOROURACIL + Panitumumab | null | null | CISPLATIN + FLUOROURACIL + RT | 100099316 |
| 20115859 | 20157739 | 1.51 | 80.5 | null | null | 2018-03-04 | Pemetrexed | null | N | CABOZANTINIB | 100803512 |
| 20115948 | 20157740 | 1.56 | 65.2 | 03 | 2019-12-20 | 2019-12-26 | POMALIDOMIDE | 01 | N | NAB-PACLITAXEL | 100827281 |
| 20116757 | 20157741 | 1.79 | 82 | null | 2022-03-16 | 2022-03-16 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100521669 |
| 20117027 | 20157742 | 1.56 | 64.1 | Neo-adjuvant (N) | 2018-03-08 | 2018-04-20 | CAPECITABINE + OXALIPLATIN + PEMBROLIZUMAB | N | N | CISPLATIN + TEYSUNO | 101790858 |
| 20117132 | 20157743 | 1.57 | null | Palliative (P) | null | 2018-03-28 | ECF | 02 | N | PACLITAXEL + RAMUCIRUMAB | 101176873 |
| 20117565 | 20157745 | 1.84 | 79.9 | Curative (C) | 2018-03-03 | 2018-03-13 | EOF | 02 | N | PERTUZUMAB | 100260787 |
| 20117638 | 20157746 | 1.53 | 41.5 | Palliative (P) | 2020-04-10 | 2020-06-27 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | CISPLATIN + FLUOROURACIL + RT | 100909407 |
| 20117727 | 20157747 | 1.71 | 66.2 | null | 2021-01-06 | 2021-01-06 | Gemcitabine + Oxaliplatin | 02 | null | BEVACIZUMAB + CAPECITABINE + IRINOTECAN | 100676526 |
| 20117837 | 20157749 | 1.69 | 86.5 | Palliative (P) | 2018-09-28 | 2018-10-05 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CISPLATIN + FLUOROURACIL + RT | 100282376 |
| 20117981 | 20157750 | 1.72 | 61 | null | 2019-01-20 | 2019-11-05 | FLUOROURACIL + INTERFERON ALFA | 02 | null | AML18 TRIAL | 101145410 |
| 20118600 | 20157751 | 1.5 | 91.9 | Palliative (P) | 2016-11-30 | 2016-11-30 | Bevacizumab + Cape + Irino 14day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101652537 |
| 20118980 | 20157752 | 1.58 | 93.2 | Palliative (P) | 2020-03-16 | 2020-03-20 | Carboplatin + Cetux + FU (Cycle 1) | N | N | CAPECITABINE + DOCETAXEL | 100678225 |
| 20119084 | 20157753 | 1.8 | 97.8 | Palliative (P) | 2018-08-18 | 2018-10-05 | AFATINIB | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100909922 |
| 20119269 | 20157756 | 1.69 | 55.8 | Palliative (P) | 2019-11-04 | 2019-11-18 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | STS NON-RHABDO EPSSG 2005 IVA | 100672395 |
| 20119473 | 20157757 | 1.75 | 68.5 | Curative (C) | 2018-12-17 | 2019-09-25 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | ATEZOLIZUMAB | 100260275 |